Illustrative image – not actual.Torrent Pharmaceuticals has drawn plans to invest around Rs.100 crore to double its R&D infrastructure and operations over the next 18 months.
The company plans to recruit around 300 scientists to undertake cutting edge discovery research and to generate a broad based generic pipeline. The project would be implemented in three phases.
The proposed research centre would be set up at the company's existing R&D premises near Gandhinagar in Gujarat.
Torrent is also setting up a formulations manufacturing facility at Baddi in Himachal Pradesh with an investment of Rs.100 crore. Meanwhile, the company would also invest Rs.24 crore at its existing API facility Chhatral in Gujarat, to upgrade to US FDA standards.
